In the BioHarmony Drug Report Database

"Preview" Icon

Tezacitabine

Hivid, Dacogen (tezacitabine) is a small molecule pharmaceutical. Tezacitabine was first approved as Hivid on 1992-06-19. It has been approved in Europe to treat myeloid leukemia.

 

Trade Name

 

Dacogen
 

Common Name

 

tezacitabine
 

ChEMBL ID

 

CHEMBL3989496
 

Indication

 

myeloid leukemia
 

Drug Class

 

Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives

Image (chem structure or protein)

Tezacitabine structure rendering